Breadcrumb
New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...
RI-MUHC ANNUAL REPORT 2021YOUR SUPPORTTOGETHER WE HAVE THE MEANS TO LEVERAGE DISCOVERIES THAT IMPROVE THE HEALTH OF PATIENTS ACROSS THEIR...
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells
A new study published in The Lancet finds that survival for babies born with a birth defect – otherwise known...
Researchers awarded funds from the Canadian Donation and Transplantation Research Program for...
RI-MUHC researcher Thao Huynh has been awarded a grant from Pfizer to conduct the IMPACT QUEBEC COVID-19 Long Haul Study
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
RI-MUHC researchers advocate for extra vigilance with feverish infants as new study shows startling numbers of serious bacterial infections during...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWCARDIOVASCULAR HEALTH ACROSS THE LIFESPAN (CHAL) PROGRAMRESEARCH HIGHLIGHTSPersonalizing...
RI-MUHC ANNUAL REPORT 2021EXECUTIVE MESSAGESMESSAGE FROM MIGUEL BURNIER JR.During this extraordinary year, the COVID-19 pandemic forced the...
RI-MUHC ANNUAL REPORT 2021FUNDING SUMMARY AND WORLDWIDE NETWORKWe are proud of our researchers’ success in funding competitions and...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWTRANSLATIONAL RESEARCH IN RESPIRATORY DISEASES (RESP) PROGRAMRESEARCH HIGHLIGHTSHarnessing the...
RI-MUHC ANNUAL REPORT 2021THE RI-MUHC IN NUMBERS: 2020-2021 472 active members,including fundamental,clinical and evaluativeresearchers...
RI-MUHC ANNUAL REPORT 2021BUSINESS DEVELOPMENT ACTIVITIESREPURPOSING AN EXISTING DRUG TO TREAT COVID-19Dr. Elena Netchiporouk embarked on a...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWINFECTIOUS DISEASES AND IMMUNITY IN GLOBAL HEALTH (IDIGH) PROGRAMRESEARCH HIGHLIGHTSFirst...
Fundamentally changing how cardiologists approach older patients
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWMETABOLIC DISORDERS AND COMPLICATIONS (MeDiC) PROGRAMRESEARCH HIGHLIGHTSUnderstanding the health...
RI-MUHC Annual Report
RI-MUHC Annual Report
Cellular Therapy Laboratory (CTL)The Cellular Therapy Laboratory (CTL) at the RI-MUHC was created to enhance research capabilities using...
Platform News
Research Life
What's New at the RI-MUHC ?
Congratulations to Tho-Alfakar Al-Aubodah!
RI-MUHC scientist Dr. Cecilia Costiniuk is co-principal investigator in a new national study that hopes to answer critical questions around the...